TY - JOUR
T1 - The Natural History of Leber Congenital Amaurosis and Cone–Rod Dystrophy Associated with Variants in the GUCY2D Gene
AU - Hahn, Leo C.
AU - Georgiou, Michalis
AU - Almushattat, Hind
AU - van Schooneveld, Mary J.
AU - de Carvalho, Emanuel R.
AU - Wesseling, Nieneke L.
AU - ten Brink, Jacoline B.
AU - Florijn, Ralph J.
AU - Lissenberg-Witte, Birgit I.
AU - Strubbe, Ine
AU - van Cauwenbergh, Caroline
AU - de Zaeytijd, Julie
AU - Walraedt, Sophie
AU - de Baere, Elfride
AU - Mukherjee, Rajarshi
AU - McKibbin, Martin
AU - Meester-Smoor, Magda A.
AU - Thiadens, Alberta A. H. J.
AU - Al-Khuzaei, Saoud
AU - Akyol, Engin
AU - Lotery, Andrew J.
AU - van Genderen, Maria M.
AU - Ossewaarde-van Norel, Jeannette
AU - van den Born, L. Ingeborgh
AU - Hoyng, Carel B.
AU - Klaver, Caroline C. W.
AU - Downes, Susan M.
AU - Bergen, Arthur A.
AU - Leroy, Bart P.
AU - Michaelides, Michel
AU - Boon, Camiel J. F.
N1 - Funding Information: Supported by the ODAS foundation (grant 2018-2 [C.J.F.B]) and the European Society of Retina Specialists (EURETINA Clinical Research Award 2019, grant 2019-1974 [L.C.H., C.J.F.B]). Funding Information: The collection of data in the participating centers was partially supported by the Ghent University Special Research Fund (BOF15/GOA/011 to E.D.B. and BOF20/GOA/023 to E.D.B. and B.P.L.) and by the Ghent University Hospital Innovation Fund (NucleUZ to E.D.B.). E.D.B. (1802220N) and B.P.L. (1803821N) are Senior Clinical Investigators of the Fonds voor Wetenschappelijk Onderzoek. Furthermore, this work has also been supported by grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology , Moorfields Eye Charity , and Retina UK. The Oxford EYE Hospital was supported by the Oxfordshire and South Midlands Clinical Research Network and the UK Inherited Retinal Dystrophy Consortium Project (Retina UK, GR586). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Saoud Al-Khuzaei is supported by a scholarship from the Qatar National Research Fund (GSRA6-1-0329-19010). The RD5000 consortium was supported by Uitzicht (grant 2015-30 financed by ODAS, Oogfonds, Retinafonds and Bartiméus Sonneheerdt). Funding Information: The collection of data in the participating centers was partially supported by the Ghent University Special Research Fund (BOF15/GOA/011 to E.D.B. and BOF20/GOA/023 to E.D.B. and B.P.L.) and by the Ghent University Hospital Innovation Fund (NucleUZ to E.D.B.). E.D.B. (1802220N) and B.P.L. (1803821N) are Senior Clinical Investigators of the Fonds voor Wetenschappelijk Onderzoek. Furthermore, this work has also been supported by grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, Moorfields Eye Charity, and Retina UK. The Oxford EYE Hospital was supported by the Oxfordshire and South Midlands Clinical Research Network and the UK Inherited Retinal Dystrophy Consortium Project (Retina UK, GR586). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Saoud Al-Khuzaei is supported by a scholarship from the Qatar National Research Fund (GSRA6-1-0329-19010). The RD5000 consortium was supported by Uitzicht (grant 2015-30 financed by ODAS, Oogfonds, Retinafonds and Bartiméus Sonneheerdt). Publisher Copyright: © 2022 American Academy of Ophthalmology
PY - 2022/8
Y1 - 2022/8
N2 - Objective: To describe the spectrum of Leber congenital amaurosis (LCA) and cone–rod dystrophy (CORD) associated with the GUCY2D gene and to identify potential end points and optimal patient selection for future therapeutic trials. Design: International, multicenter, retrospective cohort study. Subjects: Eighty-two patients with GUCY2D-associated LCA or CORD from 54 families. Methods: Medical records were reviewed for medical history, best-corrected visual acuity (BCVA), ophthalmoscopy, visual fields, full-field electroretinography, and retinal imaging (fundus photography, spectral-domain OCT [SD-OCT], fundus autofluorescence). Main Outcomes Measures: Age of onset, evolution of BCVA, genotype–phenotype correlations, anatomic characteristics on funduscopy, and multimodal imaging. Results: Fourteen patients with autosomal recessive LCA and 68 with autosomal dominant CORD were included. The median follow-up times were 5.2 years (interquartile range [IQR] 2.6–8.8 years) for LCA and 7.2 years (IQR 2.2–14.2 years) for CORD. Generally, LCA presented in the first year of life. The BCVA in patients with LCA ranged from no light perception to 1.00 logarithm of the minimum angle of resolution (logMAR) and remained relatively stable during follow-up. Imaging for LCA was limited but showed little to no structural degeneration. In patients with CORD, progressive vision loss started around the second decade of life. The BCVA declined annually by 0.022 logMAR (P < 0.001) with no difference between patients with the c.2513G>A and the c.2512C>T GUCY2D variants (P = 0.798). At the age of 40 years, the probability of being blind or severely visually impaired was 32%. The integrity of the ellipsoid zone (EZ) and that of the external limiting membrane (ELM) on SD-OCT correlated significantly with BCVA (Spearman ρ = 0.744, P = 0.001, and ρ = 0.712, P < 0.001, respectively) in those with CORD. Conclusions: Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy and available imaging, suggesting long preservation of photoreceptors. Despite large variability, GUCY2D-associated CORD generally presented during adolescence, with a progressive loss of vision, and culminated in severe visual impairment during mid-to-late adulthood. The integrity of the ELM and EZ may be suitable structural end points for therapeutic studies of GUCY2D-associated CORD.
AB - Objective: To describe the spectrum of Leber congenital amaurosis (LCA) and cone–rod dystrophy (CORD) associated with the GUCY2D gene and to identify potential end points and optimal patient selection for future therapeutic trials. Design: International, multicenter, retrospective cohort study. Subjects: Eighty-two patients with GUCY2D-associated LCA or CORD from 54 families. Methods: Medical records were reviewed for medical history, best-corrected visual acuity (BCVA), ophthalmoscopy, visual fields, full-field electroretinography, and retinal imaging (fundus photography, spectral-domain OCT [SD-OCT], fundus autofluorescence). Main Outcomes Measures: Age of onset, evolution of BCVA, genotype–phenotype correlations, anatomic characteristics on funduscopy, and multimodal imaging. Results: Fourteen patients with autosomal recessive LCA and 68 with autosomal dominant CORD were included. The median follow-up times were 5.2 years (interquartile range [IQR] 2.6–8.8 years) for LCA and 7.2 years (IQR 2.2–14.2 years) for CORD. Generally, LCA presented in the first year of life. The BCVA in patients with LCA ranged from no light perception to 1.00 logarithm of the minimum angle of resolution (logMAR) and remained relatively stable during follow-up. Imaging for LCA was limited but showed little to no structural degeneration. In patients with CORD, progressive vision loss started around the second decade of life. The BCVA declined annually by 0.022 logMAR (P < 0.001) with no difference between patients with the c.2513G>A and the c.2512C>T GUCY2D variants (P = 0.798). At the age of 40 years, the probability of being blind or severely visually impaired was 32%. The integrity of the ellipsoid zone (EZ) and that of the external limiting membrane (ELM) on SD-OCT correlated significantly with BCVA (Spearman ρ = 0.744, P = 0.001, and ρ = 0.712, P < 0.001, respectively) in those with CORD. Conclusions: Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy and available imaging, suggesting long preservation of photoreceptors. Despite large variability, GUCY2D-associated CORD generally presented during adolescence, with a progressive loss of vision, and culminated in severe visual impairment during mid-to-late adulthood. The integrity of the ELM and EZ may be suitable structural end points for therapeutic studies of GUCY2D-associated CORD.
KW - Cone–rod dystrophy
KW - GUCY2D
KW - Inherited retinal dystrophies
KW - Leber congenital amaurosis
KW - Phenotype
UR - http://www.scopus.com/inward/record.url?scp=85129606280&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.oret.2022.03.008
DO - https://doi.org/10.1016/j.oret.2022.03.008
M3 - Article
C2 - 35314386
SN - 2468-6530
VL - 6
SP - 711
EP - 722
JO - Ophthalmology Retina
JF - Ophthalmology Retina
IS - 8
ER -